US pharmaceutical companies have increased the price of drugs dozens of times through "replacing old drugs with new ones"

Source: globegroup.com September 22, 2015 according to Hong Kong's wenhui.com, Turing, the US drug manufacturer, bought the franchise of daraprim, a drug for the treatment of fatal toxoplasmosis and malaria in August After that, the price of daraprim was increased by 55 times to $750 per pill from $13.50 per pill overnight (about 4776 yuan), which increases the annual treatment cost of some patients who need to take the medicine to hundreds of thousands of dollars Oberi, director of the infectious diseases department of Icahn Medical College in Sinai mountain, New York, criticized that the price increase of the drug factory forced the hospital to switch to other treatments with poor efficacy or poor efficacy, and some hospitals were unable to purchase drugs for reserve or delay treatment He questioned that the drug factory was making huge profits, describing this kind of situation as "very dangerous" Daraprim has been on the market for 62 years Scherlie, the founder and President of Turing, argues that the drug is not widely used and many patients will not take it for more than a year Therefore, the price increase has a slight impact on the medical system, which explains that the company will use the relevant revenue to develop new drugs with fewer side effects However, some doctors questioned shikleli's claim that there are currently ways to control the side effects of daraprim In early September, the American Society of infectious diseases and the AIDS drug association also went to Turing to complain that the price hike was unfair to patients in urgent need of drugs and made the medical system unsustainable According to reports, a medical organization is investigating the price increase In fact, it is reported that in recent years, many pharmaceutical companies in the United States have bought old drugs and then packaged them into special drugs for sale at a high price, which often increases several times or even tens of times Congress had earlier investigated whether Valeant would raise the price of two heart disease drugs by two to five times.